Lucius Ovisibat – Online kaufen

IDR 5,699,993

400+ terjual
Harga Promo

Apotek fisik Hong Kong dengan jaminan produk asli 100%

Keunggulan Produk

Indicated for the treatment of cholestatic pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC), and in patients 12 months of age and older with Alagille syndrome (ALGS).

Jaminan Layanan

Pengiriman Lintas NegaraApotek ResmiDitinjau ApotekerJaminan Keaslian

Spesifikasi

Spesifikasi
400mcg*30 capsules
Produsen
Lucius Pharmaceuticals
Pengiriman
Hong Kong

Stok 10000

Informasi Produk

Nama Inggris
Odevixibat
Nama Generik
Odevixibat

Spesifikasi

Spesifikasi
400mcg*30 capsules
Produsen
Lucius Pharmaceuticals
Pengiriman
Hong Kong

Rincian Lengkap

Indikasi

Indicated for the treatment of cholestatic pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC), and in patients 12 months of age and older with Alagille syndrome (ALGS).

Mekanisme Kerja

IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]

Farmakologi

12.1 Mekanisme Kerja IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]

Dosis dan Penggunaan

2.1 3 PFIC BYLVAY 40 mcg/kg, , 1 3 , 40 mcg/kg , 120 mcg/kg, 6 mg BYLVAY 19.5 kg BYLVAY 19.5 kg

Peringatan

5.1 BYLVAY (DILI) PFIC ALGS , 6 DILI ,2 ALGS PFIC , 6 8 , , BYLVAY ,

Kontraindikasi

IBAT BYLVAY , [ Peringatan 5.1 ]

Interaksi Obat

7.1 , BYLVAY 4 4 [ Dosis dan Penggunaan (2.3)] , BYLVAY

Efek Samping

[ Peringatan(5.1)] [ Peringatan(5.2)] [ Peringatan(5.3)] 6.1 , , PFIC 1 24 , BYLVAY 40 mcg/kg 120 mcg/kg [ (14.1)]

Package Insert

Ingredients

11 BYLVAY BYLVAY IBAT , (2S)-2-{[(2R)-2-(2-{[3,3- -7-( )-1,1- -5- -2,3,4,5- -1H-1λ 6 ,2,5- -8- ] } )-2-(4- ) ] } , , C 37 H 48 N 4 O 8 S 2 × 1.5 H 2 O, 768.0 g/mol 740.9 g/mol pH , pH BYLVAY , , 200 600

Indications

Indicated for the treatment of cholestatic pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC), and in patients 12 months of age and older with Alagille syndrome (ALGS).

Dosis dan Penggunaan

2.1 3 PFIC BYLVAY 40 mcg/kg, , 1 3 , 40 mcg/kg , 120 mcg/kg, 6 mg BYLVAY 19.5 kg BYLVAY 19.5 kg

Efek Samping

[ Peringatan(5.1)] [ Peringatan(5.2)] [ Peringatan(5.3)] 6.1 , , PFIC 1 24 , BYLVAY 40 mcg/kg 120 mcg/kg [ (14.1)]

Kontraindikasi

IBAT BYLVAY , [ Peringatan 5.1 ]

Precautions

5.1 BYLVAY (DILI) PFIC ALGS , 6 DILI ,2 ALGS PFIC , 6 8 , , BYLVAY ,

Use in Pregnancy and Lactation

8.1 BYLVAY , ,BYLVAY , odevixibat , 2.1

Interaksi Obat

7.1 , BYLVAY 4 4 [ Dosis dan Penggunaan (2.3)] , BYLVAY

Clinical Pharmacology

12 12.1 Mekanisme Kerja (IBAT) (PFIC) (ALGS) PFIC PFIC ALGS , IBAT , , [ (12.2)] 12.2 PFIC ALGS

Pharmacology and Toxicology

13 13.1 2 , 100 mg/kg/ odevixibat , AUC 231 459 Ames 1000 mg/kg/

Clinical Studies

14 14.1 PFIC BYLVAY 1 (NCT03566238) , 24 1 62 6 17 , PFIC 1 2 , 1 , ABCB11 BSEP INR 1.4 ALT ULN 10 n=20 40 mcg/kg n=23 120 mcg/kg n=19

Ulasan Produk (15)

Filter: All Reviews
4.8★★★★★
+o***e· 3周前
★★★★
+t***3· 1个月前
Pembelian Terverifikasi
★★★★★

Deskripsi produk

Indikasi

Indicated for the treatment of cholestatic pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC), and in patients 12 months of age and older with Alagille syndrome (ALGS).

Mekanisme Kerja

IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]

Farmakologi

12.1 Mekanisme Kerja IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]

Dosis dan Penggunaan

2.1 3 PFIC BYLVAY 40 mcg/kg, , 1 3 , 40 mcg/kg , 120 mcg/kg, 6 mg BYLVAY 19.5 kg BYLVAY 19.5 kg

Peringatan

5.1 BYLVAY (DILI) PFIC ALGS , 6 DILI ,2 ALGS PFIC , 6 8 , , BYLVAY ,

Kontraindikasi

IBAT BYLVAY , [ Peringatan 5.1 ]

Interaksi Obat

7.1 , BYLVAY 4 4 [ Dosis dan Penggunaan (2.3)] , BYLVAY

Efek Samping

[ Peringatan(5.1)] [ Peringatan(5.2)] [ Peringatan(5.3)] 6.1 , , PFIC 1 24 , BYLVAY 40 mcg/kg 120 mcg/kg [ (14.1)]